Vldl cholesterol range
Searched over 200M research papers
Summary
10 papers analyzed
These studies suggest VLDL cholesterol is a significant factor in cardiovascular disease risk, myocardial infarction, and coronary artery calcification, with its levels influenced by gender, menopausal status, and pharmacological interventions.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta20 papers analyzed
Understanding VLDL Cholesterol Range and Its Implications
VLDL Cholesterol Estimation and Range
Very low-density lipoprotein cholesterol (VLDL-C) is a type of lipoprotein that carries triglycerides in the blood. The estimation of VLDL-C is often derived from plasma triglyceride (TG) levels using the Friedewald equation: VLDL-C = 0.20 (TG). This method has been validated for TG values up to 4,000 mg/l, but caution is advised for TG values exceeding 10,000 mg/l due to increasing imprecision. An alternative equation, VLDL-C = 0.166 (TG), has shown equal or improved accuracy, particularly at high TG levels.
VLDL Cholesterol and Cardiovascular Risk
VLDL cholesterol is a significant predictor of cardiovascular events. Studies have shown that higher levels of VLDL-C are associated with an increased risk of myocardial infarction (MI). For instance, a 1-mmol/l increase in VLDL-C was associated with a hazard ratio of 2.07 for MI, indicating a substantial risk. Furthermore, VLDL-C explained 50% of the MI risk from elevated apolipoprotein B (apoB)-containing lipoproteins, highlighting its critical role in cardiovascular risk assessment.
Gender and Menopausal Differences in VLDL Cholesterol
Research has documented significant gender and menopausal status differences in VLDL-C levels. Men generally have higher large VLDL-C levels, while women have higher small VLDL-C levels. Postmenopausal women exhibit higher levels of VLDL-C compared to premenopausal women, indicating hormonal influences on lipid metabolism.
VLDL Cholesterol and Residual Cardiovascular Risk
Even with low LDL-C levels achieved through statin therapy, VLDL-C remains a significant contributor to residual cardiovascular risk. Reductions in small, cholesterol-enriched VLDL particles have been associated with decreased atherosclerotic cardiovascular disease (ASCVD) risk, suggesting that VLDL-C is a crucial target for further risk reduction beyond LDL-C lowering .
VLDL Cholesterol in Obesity and Myocardial Infarction
Obesity is associated with higher VLDL-C levels, which in turn contribute significantly to the increased risk of myocardial infarction in obese individuals. VLDL-C explained 40% of the excess MI risk in individuals with higher body mass index (BMI), underscoring the importance of managing VLDL-C in obese populations to mitigate cardiovascular risk.
VLDL Cholesterol and Recurrent Cardiovascular Events
In patients with existing cardiovascular disease, VLDL-C levels have been linked to recurrent major adverse cardiovascular events (MACE) and major adverse limb events (MALE). However, VLDL-C was not associated with all-cause mortality, indicating its specific role in certain cardiovascular outcomes.
Conclusion
VLDL cholesterol is a critical factor in cardiovascular health, influencing the risk of myocardial infarction, especially in individuals with high triglyceride levels, obesity, and those undergoing statin therapy. Understanding and managing VLDL-C levels can significantly impact cardiovascular risk reduction strategies, highlighting the need for comprehensive lipid profiling in clinical practice.
Sources and full results
Most relevant research papers on this topic
